TL;DR
Get everyday helpers delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
MedPage Today published a roundup of comments its reporters heard during the week, covering AI in health care, access to a new flu shot and findings across several medical topics. The quotations capture experts’ reactions, but the roundup does not provide enough study detail to assess the underlying research independently.
MedPage Today published a weekly roundup on October 18, 2026, collecting comments from researchers and clinicians on AI in health care, flu-shot access and several medical studies. The remarks offer snapshots of how experts frame these issues, but the roundup is a collection of quotations rather than a full account of the studies or developments discussed.
The headline quotation came from Mishal Khan, PhD, of the UC Berkeley Labor Center, speaking about artificial intelligence in health care: “Tech is not good or bad, but neither is it neutral.” Her statement frames technology as something whose effects depend on how it is designed and used, rather than as inherently beneficial or harmful. The item does not give further detail about the specific AI application or research prompting the comment.
Other remarks addressed practical access and interpretation of evidence. Amesh Adalja, MD, of the Johns Hopkins Center for Health Security, said people seeking the new mRNA flu shot mFlusiva would have to use its website or call around. On pregnancy research, Krista Huybrechts, MS, PhD, of Brigham and Women’s Hospital, described findings on early-pregnancy benzodiazepine use and congenital malformations as reassuring while adding that the drugs are not risk-free.
The roundup also included comments about pulmonary vascular resistance after heart transplantation, cancer risk among people with sickle cell disease, long-acting HIV therapy, pediatric obesity screening and the reality television program “The Swan.” Each quotation is attributed to a named expert and institution. The short format does not provide study methods, sample sizes, numerical results or other details needed to evaluate the cited research.
Experts Flag Access and Evidence Questions
The comments bring together issues that affect how health care is delivered and how new evidence is interpreted. Khan’s observation about AI directs attention beyond whether a tool works to who designs it, how it is deployed and who may be affected. The roundup does not specify a particular system or outcome, so the quotation should be read as a general caution, not as a finding about a named AI product.
Adalja’s remark points to a more immediate practical question: how patients can locate and obtain mFlusiva. The statement describes a possible search burden, but the roundup does not establish the shot’s availability by location, eligibility requirements, cost or how many people may face difficulty accessing it. The research quotations likewise underline that reassuring or notable findings are not the same as a definitive conclusion. Readers need the underlying evidence and its limits to understand what each study means for clinical care.
As an affiliate, we earn on qualifying purchases.
Eight Topics in One Weekly Roundup
MedPage Today describes the piece as a collection of quotations heard by its reporters during the week. The October 18 entry covers a range of subjects rather than reporting a single study or policy announcement. The quotes span technology, vaccination access, pregnancy, transplantation and public health, alongside comments about plastic surgery and obesity screening.
Several speakers explicitly point to limits in interpreting evidence. Ahmed Zayed, MBBCh, of Staten Island University Hospital, said the goal in studying pulmonary vascular resistance after heart transplantation is not to discard the measure but to stop reading it in isolation. On sickle cell disease and cancer risk, Vijay Sankaran, MD, PhD, of Harvard Medical School and Boston Children’s Hospital, said the “burden of proof remains to be shown.” These brief remarks provide context for the issues, but not the full findings or the researchers’ methods.
““Tech is not good or bad, but neither is it neutral.””
— Mishal Khan, PhD, UC Berkeley Labor Center
As an affiliate, we earn on qualifying purchases.
Study Details Are Not Included
The roundup does not provide links to or summaries of the underlying studies, including their design, participant numbers, results or limitations. It is therefore not possible from this source alone to determine how strong or generalizable the findings are. The remarks should be treated as attributed comments, not substitutes for the research.
Several practical details also remain unspecified. The item does not clarify where mFlusiva is available, who can receive it or what access routes are officially offered. It also gives no additional information about the AI applications Khan had in mind. The comments on HIV treatment, transplant outcomes and pediatric obesity screening similarly lack the detail needed to draw conclusions about clinical recommendations.
As an affiliate, we earn on qualifying purchases.
Underlying Research Offers the Next Step
Readers seeking more than the experts’ short remarks will need to consult the studies and reporting associated with each topic. Those sources would establish what was measured, what the results showed and where uncertainty remains. For mFlusiva, information from the relevant manufacturer, health providers or public health authorities would be needed to clarify availability, eligibility and access procedures.
MedPage Today’s item does not announce a forthcoming policy decision, study release or follow-up date. The next developments are therefore uncertain; any changes in vaccine access or new evidence on the research topics would need to be confirmed through subsequent reporting or official updates.
long-acting HIV therapy medications
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What did MedPage Today publish?
It published a weekly roundup of quotations from researchers and clinicians, dated October 18, 2026. The comments cover several health and medical research topics.
What was the quote about AI in health care?
Mishal Khan of the UC Berkeley Labor Center said: “Tech is not good or bad, but neither is it neutral.” The roundup does not name a specific AI system or describe the research behind the comment.
What does the roundup say about mFlusiva access?
Amesh Adalja said people seeking the mRNA flu shot would have to use its website or call around. The item does not specify locations, eligibility, cost or confirmed distribution details.
Does the article provide enough detail to evaluate the studies?
No. It gives brief attributed comments but does not include study methods, sample sizes or full results. The quotations alone do not establish clinical guidance or prove a study’s conclusions.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
